“D” is for Diagnosis: The Radiologist’s Role in Detecting and Diagnosing Rare Interstitial Lung Diseases

Live Webinar Sponsored By Boehringer Ingelheim Pharmaceuticals, Inc.

Thursday, August 13, 8:00–9:00 pm Eastern Time

Complimentary Registration

Chair

Ami Rubinowitz, MD
Associate Professor of Radiology & Biomedical Imaging Thoracic Imaging Section
Yale School of Medicine
Yale New Haven Hospital

Faculty

Michael Kadoch, MD
Mount Sinai Hospital

Lisa Lancaster, MD
Professor of Medicine
Director, Interstitial Lung Disease Program
Vanderbilt University Medical Center

Jonathan H. Chung, MD
Professor of Radiology
Chief Quality Officer, Department of Radiology
Section Chief, Thoracic Radiology
The University of Chicago Medicine

Interstitial lung diseases (ILDs) are a multifaceted group of lung disorders with similar clinical, physiologic, pathologic, and radiologic characteristics. In progressive or severe forms, ILDs lead to progressive loss of lung function, respiratory failure, decreased quality of life, and early mortality. Although considered rare, the incidence of ILDs by either unknown causes or associations with other diseases or environmental exposures has increased along with more complex and expanding disease classification.

During this highly interactive, game-style symposium, the audience will be encouraged to examine ‘mystery’ cases, look for clues from the clinical history and presentation, evaluate radiologic imaging and other diagnostic test results, and ultimately uncover the correct diagnosis. Expert faculty will then reveal the underlying disease and review therapeutic options.

Learning Outcomes

Upon completion of this activity, participants will be able to:

  1. Describe the pathophysiology of multiple ILD subtypes and how these mechanisms influence diagnostic signs, symptoms, and radiologic findings.
  2. Interpret radiographic patterns on high-resolution computed tomography (HRCT) to differentially diagnose ILDs.
  3. Evaluate efficacy and tolerability of new and emerging treatments for ILD subtypes and potential use in clinical practice.

This educational activity is directed toward radiologists, pulmonologists, pathologists, PAs, NPs, and additional health care professionals who are involved in the diagnosis of ILDs.

Acknowledgement of Commercial Support

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Complimentary Registration

The Lunch Symposia are not part of the ARRS CME program, and ARRS has had no role in the development of the content. Any opinions or conclusions expressed are solely those of the presenters. Where noted, CME is made available by third party providers. Credit must be claimed through the accrediting organization and separately from ARRS.